SCHEMBL3781405

SCHEMBL3781405

C=CCc1cc(N)nc(Cc2ccccc2)n1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
CYP3A4 P08684 2/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2D6 P10635 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
MPO P05164 3/20 0.38
TPO P07202 1/20 0.38
EPX P11678 1/20 0.38
NOS3 P29474 1/20 0.36
NOS1 P29475 1/20 0.36
NOS2 P35228 1/20 0.36
HTR6 P50406 1/20 0.35
HRH4 Q9H3N8 1/20 0.35
ADORA2A P29274 1/20 0.35
ADORA2B P29275 1/20 0.35
ADORA1 P30542 1/20 0.35
TDP1 Q9NUW8 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8012292 0.80 MAPT (0.39) NOS3NOS2TDP1
SCHEMBL28267391 0.80 NPC1 (0.53) NPC1RAB9ASMN1; SMN2CYP3A4CYP1A2
SCHEMBL15912796 0.72 MPO (0.45) NPC1RAB9ASMN1; SMN2CYP3A4CYP1A2
SCHEMBL30665479 0.72 MPO (0.45) NPC1RAB9ASMN1; SMN2CYP3A4CYP1A2
SCHEMBL15520859 0.71 DHFR (0.32) NOS3NOS2HRH4TDP1
SCHEMBL2614741 0.68 CALM1 (0.61) NPC1RAB9ASMN1; SMN2CYP3A4CYP1A2
SCHEMBL16399558 0.67 ALDH1A1 (0.46) NPC1RAB9ASMN1; SMN2CYP3A4MPO
SCHEMBL12290980 0.67 CALM1 (0.55) NPC1RAB9ASMN1; SMN2CYP3A4MPO
SCHEMBL3416553 0.67 HTR6 (0.57) NPC1RAB9ASMN1; SMN2CYP3A4CYP1A2
SCHEMBL29376725 0.67 NCF1 (0.50) NPC1RAB9ASMN1; SMN2CYP1A2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2205570-A1 2-S-BENZYL SUBSTITUTED PYRIMIDINES AS CRTH2 ANTAGONISTS Actimis Pharmaceuticals, Inc., (US) 2010-07-14 EP disclosed
WO-2009042139-A1 2-S-BENZYL SUBSTITUTED PYRIMIDINES AS CRTH2 ANTAGONISTS ACTIMIS PHARMACEUTICALS, INC. (US) 2009-04-02 WO disclosed